Marguerite Kelher
Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neutrophils | 25 | 2020 | 1233 | 2.110 |
Why?
| Acute Lung Injury | 11 | 2017 | 310 | 1.660 |
Why?
| Blood Preservation | 14 | 2018 | 311 | 1.600 |
Why?
| Erythrocytes | 10 | 2018 | 641 | 1.350 |
Why?
| Blood Coagulation Disorders | 8 | 2023 | 208 | 1.150 |
Why?
| Fibrinolysis | 7 | 2023 | 159 | 1.080 |
Why?
| Blood Proteins | 6 | 2018 | 248 | 1.080 |
Why?
| Neutrophil Activation | 6 | 2018 | 100 | 1.010 |
Why?
| Blood Platelets | 12 | 2022 | 369 | 0.990 |
Why?
| Transfusion Reaction | 10 | 2016 | 79 | 0.970 |
Why?
| Erythrocyte Transfusion | 7 | 2017 | 210 | 0.940 |
Why?
| Antibodies | 3 | 2016 | 392 | 0.870 |
Why?
| Lysophosphatidylcholines | 4 | 2016 | 36 | 0.820 |
Why?
| NADPH Oxidases | 6 | 2016 | 138 | 0.760 |
Why?
| Leukocyte Reduction Procedures | 2 | 2018 | 28 | 0.750 |
Why?
| Protein Kinase C | 2 | 2017 | 297 | 0.640 |
Why?
| Plasma | 6 | 2020 | 224 | 0.630 |
Why?
| Wounds and Injuries | 7 | 2023 | 772 | 0.630 |
Why?
| Proto-Oncogene Proteins c-hck | 2 | 2016 | 5 | 0.610 |
Why?
| Cell Membrane | 6 | 2016 | 710 | 0.600 |
Why?
| Tissue Plasminogen Activator | 8 | 2023 | 231 | 0.580 |
Why?
| Protein Kinase C-delta | 1 | 2016 | 69 | 0.550 |
Why?
| Histocompatibility Antigens Class II | 1 | 2016 | 355 | 0.510 |
Why?
| Blood Component Transfusion | 3 | 2020 | 84 | 0.480 |
Why?
| Lipid Metabolism | 1 | 2017 | 477 | 0.470 |
Why?
| Thrombin | 5 | 2023 | 143 | 0.440 |
Why?
| Platelet Aggregation | 3 | 2022 | 97 | 0.430 |
Why?
| Proteomics | 7 | 2022 | 876 | 0.390 |
Why?
| Calcium | 7 | 2016 | 1169 | 0.380 |
Why?
| Thrombosis | 3 | 2023 | 309 | 0.370 |
Why?
| Plasminogen Activator Inhibitor 1 | 3 | 2023 | 82 | 0.370 |
Why?
| Transfusion-Related Acute Lung Injury | 2 | 2019 | 6 | 0.340 |
Why?
| Histocompatibility Antigens Class I | 1 | 2009 | 177 | 0.310 |
Why?
| Endothelial Cells | 5 | 2018 | 732 | 0.300 |
Why?
| Enzyme Activation | 8 | 2017 | 828 | 0.290 |
Why?
| Organ Preservation Solutions | 2 | 2018 | 44 | 0.280 |
Why?
| Platelet Activating Factor | 4 | 2019 | 95 | 0.280 |
Why?
| Fibrinolysin | 2 | 2023 | 17 | 0.260 |
Why?
| Endothelium, Vascular | 5 | 2018 | 907 | 0.260 |
Why?
| ABO Blood-Group System | 2 | 2022 | 35 | 0.260 |
Why?
| Lung | 9 | 2023 | 3664 | 0.260 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2003 | 67 | 0.250 |
Why?
| Lipids | 3 | 2017 | 607 | 0.250 |
Why?
| Arachidonic Acid | 3 | 2022 | 122 | 0.250 |
Why?
| Plateletpheresis | 3 | 2018 | 28 | 0.240 |
Why?
| Receptors, G-Protein-Coupled | 5 | 2010 | 200 | 0.240 |
Why?
| Humans | 58 | 2023 | 118974 | 0.240 |
Why?
| Tyrosine | 2 | 2003 | 233 | 0.240 |
Why?
| Carboxypeptidase B2 | 1 | 2023 | 4 | 0.230 |
Why?
| Bradykinin | 1 | 2023 | 48 | 0.230 |
Why?
| Uterine Inertia | 1 | 2022 | 2 | 0.230 |
Why?
| Isoantibodies | 2 | 2018 | 63 | 0.220 |
Why?
| Blood Component Removal | 2 | 2014 | 34 | 0.220 |
Why?
| Postpartum Hemorrhage | 1 | 2022 | 16 | 0.220 |
Why?
| Thrombelastography | 5 | 2023 | 192 | 0.220 |
Why?
| Antifibrinolytic Agents | 1 | 2023 | 44 | 0.220 |
Why?
| Hemostatics | 1 | 2023 | 50 | 0.210 |
Why?
| beta-Globins | 1 | 2022 | 16 | 0.210 |
Why?
| Blood Coagulation | 2 | 2023 | 219 | 0.210 |
Why?
| p38 Mitogen-Activated Protein Kinases | 4 | 2008 | 285 | 0.210 |
Why?
| Hemorrhage | 2 | 2023 | 623 | 0.200 |
Why?
| Metabolome | 2 | 2014 | 296 | 0.200 |
Why?
| Cytosol | 5 | 2010 | 221 | 0.200 |
Why?
| Bronchopulmonary Sequestration | 1 | 2020 | 9 | 0.200 |
Why?
| alpha-2-Antiplasmin | 1 | 2020 | 3 | 0.190 |
Why?
| Shock, Hemorrhagic | 1 | 2023 | 206 | 0.190 |
Why?
| Rats | 6 | 2023 | 5392 | 0.190 |
Why?
| Oxidoreductases | 2 | 2011 | 100 | 0.190 |
Why?
| Plasminogen | 2 | 2023 | 34 | 0.190 |
Why?
| Phosphorylation | 5 | 2016 | 1633 | 0.190 |
Why?
| Pulmonary Embolism | 1 | 2022 | 183 | 0.180 |
Why?
| Receptors, Leukotriene B4 | 2 | 2017 | 10 | 0.180 |
Why?
| Clathrin | 3 | 2010 | 31 | 0.180 |
Why?
| Respiratory Burst | 3 | 2016 | 31 | 0.180 |
Why?
| Lung Injury | 2 | 2016 | 210 | 0.180 |
Why?
| Protein Transport | 4 | 2016 | 412 | 0.170 |
Why?
| Transcription Factors | 2 | 2004 | 1570 | 0.170 |
Why?
| Cytoplasmic Granules | 1 | 2018 | 84 | 0.160 |
Why?
| Hemagglutinins | 1 | 2018 | 11 | 0.160 |
Why?
| Sex Characteristics | 2 | 2014 | 671 | 0.160 |
Why?
| Resuscitation | 1 | 2020 | 253 | 0.160 |
Why?
| Filtration | 2 | 2018 | 64 | 0.160 |
Why?
| Animals | 13 | 2023 | 33381 | 0.160 |
Why?
| Histocompatibility Testing | 1 | 2018 | 123 | 0.160 |
Why?
| Endocytosis | 2 | 2009 | 156 | 0.150 |
Why?
| Lipopolysaccharides | 3 | 2016 | 870 | 0.140 |
Why?
| Platelet Membrane Glycoproteins | 4 | 2009 | 43 | 0.140 |
Why?
| Endothelium | 1 | 2016 | 120 | 0.140 |
Why?
| Receptor, PAR-2 | 1 | 2015 | 8 | 0.140 |
Why?
| Phosphopyruvate Hydratase | 1 | 2015 | 34 | 0.130 |
Why?
| Models, Immunological | 2 | 2013 | 94 | 0.130 |
Why?
| Inflammation | 6 | 2023 | 2566 | 0.130 |
Why?
| Citrates | 1 | 2014 | 48 | 0.130 |
Why?
| Male | 21 | 2023 | 57801 | 0.130 |
Why?
| Interleukin-18 | 2 | 2009 | 228 | 0.130 |
Why?
| MAP Kinase Signaling System | 3 | 2008 | 292 | 0.130 |
Why?
| Microcirculation | 1 | 2015 | 155 | 0.130 |
Why?
| Proteome | 2 | 2023 | 353 | 0.120 |
Why?
| Sodium Chloride | 1 | 2014 | 144 | 0.120 |
Why?
| Intercellular Signaling Peptides and Proteins | 4 | 2009 | 369 | 0.120 |
Why?
| HLA-A2 Antigen | 1 | 2013 | 39 | 0.120 |
Why?
| Phosphates | 1 | 2014 | 167 | 0.120 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2023 | 613 | 0.120 |
Why?
| Cell-Derived Microparticles | 1 | 2014 | 62 | 0.110 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2003 | 298 | 0.110 |
Why?
| Female | 19 | 2023 | 61565 | 0.110 |
Why?
| Adenine | 1 | 2014 | 223 | 0.110 |
Why?
| Blood Coagulation Tests | 2 | 2023 | 58 | 0.110 |
Why?
| Recombinant Proteins | 1 | 2016 | 1308 | 0.110 |
Why?
| Superoxides | 2 | 2011 | 221 | 0.110 |
Why?
| Leukocytes, Mononuclear | 2 | 2014 | 509 | 0.110 |
Why?
| Pancreatic Neoplasms | 2 | 2010 | 734 | 0.110 |
Why?
| Fibrinogen | 2 | 2023 | 161 | 0.100 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2012 | 527 | 0.100 |
Why?
| Acute Chest Syndrome | 1 | 2011 | 3 | 0.100 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2018 | 827 | 0.100 |
Why?
| Phospholipases A2, Secretory | 1 | 2011 | 27 | 0.100 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2011 | 41 | 0.100 |
Why?
| Phosphoproteins | 3 | 2009 | 308 | 0.100 |
Why?
| Saline Solution, Hypertonic | 1 | 2011 | 56 | 0.100 |
Why?
| Platelet Transfusion | 2 | 2009 | 68 | 0.100 |
Why?
| Adenocarcinoma | 2 | 2010 | 812 | 0.100 |
Why?
| Mass Spectrometry | 4 | 2018 | 681 | 0.100 |
Why?
| Mesentery | 1 | 2011 | 56 | 0.100 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2010 | 16 | 0.100 |
Why?
| Adenosine Diphosphate | 2 | 2022 | 88 | 0.100 |
Why?
| CD40 Ligand | 2 | 2011 | 46 | 0.100 |
Why?
| Arrestins | 2 | 2010 | 15 | 0.100 |
Why?
| Platelet Activation | 2 | 2022 | 70 | 0.100 |
Why?
| Macrophages | 2 | 2010 | 1324 | 0.100 |
Why?
| Protein Binding | 1 | 2016 | 1975 | 0.100 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 540 | 0.090 |
Why?
| Protein Kinase Inhibitors | 1 | 2016 | 811 | 0.090 |
Why?
| Endosomes | 2 | 2008 | 128 | 0.090 |
Why?
| Mice, Knockout | 1 | 2016 | 2680 | 0.090 |
Why?
| Disease Models, Animal | 3 | 2010 | 3730 | 0.090 |
Why?
| Glucose | 1 | 2014 | 953 | 0.090 |
Why?
| Hydrogen-Ion Concentration | 3 | 2018 | 536 | 0.090 |
Why?
| Liver | 1 | 2018 | 1816 | 0.090 |
Why?
| Antibodies, Monoclonal | 2 | 2013 | 1284 | 0.090 |
Why?
| Amantadine | 1 | 2009 | 7 | 0.090 |
Why?
| Healthy Volunteers | 2 | 2020 | 201 | 0.090 |
Why?
| Sex Factors | 3 | 2023 | 1781 | 0.080 |
Why?
| Adult | 10 | 2023 | 31512 | 0.080 |
Why?
| Cells, Cultured | 6 | 2018 | 4077 | 0.080 |
Why?
| rab5 GTP-Binding Proteins | 1 | 2008 | 7 | 0.080 |
Why?
| Protein Kinases | 1 | 2010 | 310 | 0.080 |
Why?
| Cytokines | 1 | 2016 | 1900 | 0.080 |
Why?
| Angiogenic Proteins | 1 | 2008 | 21 | 0.080 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 2478 | 0.080 |
Why?
| Lymph Nodes | 1 | 2011 | 455 | 0.080 |
Why?
| Injury Severity Score | 2 | 2022 | 528 | 0.080 |
Why?
| Mice | 5 | 2022 | 15520 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2012 | 1171 | 0.080 |
Why?
| Actins | 2 | 2009 | 404 | 0.080 |
Why?
| Estradiol | 2 | 2022 | 476 | 0.080 |
Why?
| Time Factors | 6 | 2016 | 6412 | 0.080 |
Why?
| Carcinogens | 1 | 2008 | 108 | 0.080 |
Why?
| Pertussis Toxin | 2 | 2003 | 29 | 0.070 |
Why?
| Lung Diseases | 2 | 2004 | 718 | 0.070 |
Why?
| Isoantigens | 1 | 2006 | 19 | 0.070 |
Why?
| Cell Cycle Proteins | 1 | 2010 | 565 | 0.070 |
Why?
| In Vitro Techniques | 3 | 2020 | 1094 | 0.070 |
Why?
| Inflammation Mediators | 1 | 2009 | 502 | 0.070 |
Why?
| Neovascularization, Pathologic | 1 | 2008 | 287 | 0.070 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 341 | 0.070 |
Why?
| CD40 Antigens | 1 | 2006 | 80 | 0.070 |
Why?
| Imidazoles | 2 | 2003 | 232 | 0.070 |
Why?
| Blood Transfusion | 2 | 2022 | 306 | 0.070 |
Why?
| Leukotriene B4 | 3 | 2011 | 51 | 0.060 |
Why?
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2004 | 2 | 0.060 |
Why?
| HLA Antigens | 2 | 2018 | 230 | 0.060 |
Why?
| Blood Transfusion, Autologous | 1 | 2004 | 22 | 0.060 |
Why?
| Protein Subunits | 1 | 2005 | 211 | 0.060 |
Why?
| Pulmonary Circulation | 1 | 2006 | 424 | 0.060 |
Why?
| Prostatectomy | 1 | 2004 | 100 | 0.060 |
Why?
| Fluorescence Resonance Energy Transfer | 3 | 2010 | 183 | 0.060 |
Why?
| Blood Physiological Phenomena | 1 | 2003 | 15 | 0.060 |
Why?
| I-kappa B Proteins | 1 | 2003 | 80 | 0.060 |
Why?
| Molecular Weight | 1 | 2003 | 343 | 0.060 |
Why?
| Rodentia | 1 | 2023 | 47 | 0.060 |
Why?
| Factor XIII | 1 | 2023 | 8 | 0.060 |
Why?
| Factor V | 1 | 2023 | 23 | 0.060 |
Why?
| Hypotension | 1 | 2004 | 120 | 0.060 |
Why?
| Pyridines | 2 | 2003 | 440 | 0.060 |
Why?
| Enzyme Inhibitors | 2 | 2003 | 827 | 0.060 |
Why?
| Thromboplastin | 1 | 2022 | 68 | 0.050 |
Why?
| Hemostasis | 1 | 2023 | 70 | 0.050 |
Why?
| Egtazic Acid | 1 | 2002 | 44 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 2 | 2015 | 175 | 0.050 |
Why?
| von Willebrand Factor | 1 | 2022 | 58 | 0.050 |
Why?
| P-Selectin | 1 | 2022 | 26 | 0.050 |
Why?
| Apolipoprotein A-I | 1 | 2022 | 26 | 0.050 |
Why?
| CD36 Antigens | 1 | 2022 | 42 | 0.050 |
Why?
| alpha-Globins | 1 | 2022 | 12 | 0.050 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2014 | 490 | 0.050 |
Why?
| Pancreatic Elastase | 2 | 2016 | 74 | 0.050 |
Why?
| Cell Movement | 1 | 2005 | 896 | 0.050 |
Why?
| Metabolic Networks and Pathways | 1 | 2022 | 176 | 0.050 |
Why?
| Succinic Acid | 1 | 2020 | 46 | 0.050 |
Why?
| Trauma Severity Indices | 1 | 2020 | 127 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 407 | 0.050 |
Why?
| Receptors, Fibrinogen | 1 | 2019 | 2 | 0.050 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 420 | 0.050 |
Why?
| Platelet Function Tests | 1 | 2019 | 25 | 0.050 |
Why?
| Case-Control Studies | 2 | 2018 | 3171 | 0.040 |
Why?
| NF-kappa B | 1 | 2003 | 670 | 0.040 |
Why?
| Hemoglobins | 1 | 2022 | 326 | 0.040 |
Why?
| Blood Donors | 2 | 2014 | 109 | 0.040 |
Why?
| Fibrinolytic Agents | 1 | 2022 | 238 | 0.040 |
Why?
| Premenopause | 1 | 2019 | 108 | 0.040 |
Why?
| beta-Arrestin 1 | 2 | 2010 | 6 | 0.040 |
Why?
| beta-Arrestins | 2 | 2010 | 12 | 0.040 |
Why?
| Blood Buffy Coat | 1 | 2018 | 6 | 0.040 |
Why?
| Methods | 1 | 2018 | 67 | 0.040 |
Why?
| Testosterone | 1 | 2022 | 351 | 0.040 |
Why?
| Proteins | 1 | 2004 | 938 | 0.040 |
Why?
| Microscopy, Fluorescence | 2 | 2010 | 412 | 0.040 |
Why?
| Gene Expression | 1 | 2003 | 1489 | 0.040 |
Why?
| Blood Group Incompatibility | 1 | 2018 | 15 | 0.040 |
Why?
| Blotting, Western | 2 | 2011 | 1194 | 0.040 |
Why?
| Cycloheximide | 1 | 2018 | 57 | 0.040 |
Why?
| Solutions | 1 | 2018 | 156 | 0.040 |
Why?
| Antibody Affinity | 1 | 2018 | 55 | 0.040 |
Why?
| Leukapheresis | 2 | 2011 | 27 | 0.040 |
Why?
| Protein Synthesis Inhibitors | 1 | 2018 | 47 | 0.040 |
Why?
| Antibody Specificity | 1 | 2018 | 184 | 0.040 |
Why?
| Dynamin II | 2 | 2008 | 8 | 0.040 |
Why?
| Postmenopause | 1 | 2019 | 305 | 0.040 |
Why?
| Culture Media, Conditioned | 1 | 2017 | 112 | 0.040 |
Why?
| Middle Aged | 5 | 2019 | 27617 | 0.040 |
Why?
| Risk Factors | 2 | 2022 | 9000 | 0.040 |
Why?
| Prostatic Neoplasms | 1 | 2004 | 940 | 0.040 |
Why?
| Microvessels | 1 | 2017 | 77 | 0.040 |
Why?
| Biomarkers | 2 | 2018 | 3588 | 0.040 |
Why?
| Breast Neoplasms | 1 | 2008 | 1965 | 0.030 |
Why?
| Pregnancy | 2 | 2022 | 5691 | 0.030 |
Why?
| Epitopes | 1 | 2018 | 443 | 0.030 |
Why?
| Protein Biosynthesis | 1 | 2018 | 397 | 0.030 |
Why?
| Ligands | 2 | 2008 | 567 | 0.030 |
Why?
| Disease Management | 1 | 2019 | 571 | 0.030 |
Why?
| Postoperative Period | 1 | 2016 | 309 | 0.030 |
Why?
| Transplantation Conditioning | 1 | 2016 | 156 | 0.030 |
Why?
| Tranexamic Acid | 1 | 2015 | 37 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2019 | 1384 | 0.030 |
Why?
| Isotonic Solutions | 1 | 2014 | 43 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2004 | 2445 | 0.030 |
Why?
| 2,3-Diphosphoglycerate | 1 | 2014 | 29 | 0.030 |
Why?
| Phagocytosis | 1 | 2016 | 364 | 0.030 |
Why?
| Cold Temperature | 1 | 2014 | 132 | 0.030 |
Why?
| Prognosis | 1 | 2022 | 3443 | 0.030 |
Why?
| Postoperative Complications | 1 | 2004 | 2235 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 1419 | 0.030 |
Why?
| Receptors, Formyl Peptide | 2 | 2003 | 11 | 0.030 |
Why?
| Receptors, Peptide | 2 | 2003 | 24 | 0.030 |
Why?
| Incidence | 1 | 2019 | 2424 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 305 | 0.030 |
Why?
| Cohort Studies | 1 | 2023 | 5116 | 0.030 |
Why?
| Young Adult | 2 | 2019 | 10793 | 0.030 |
Why?
| Retrospective Studies | 2 | 2022 | 12978 | 0.030 |
Why?
| Wounds, Nonpenetrating | 1 | 2015 | 285 | 0.030 |
Why?
| Pneumonia | 1 | 2017 | 592 | 0.030 |
Why?
| Adenosine Triphosphate | 1 | 2014 | 439 | 0.030 |
Why?
| Flow Cytometry | 1 | 2015 | 1085 | 0.030 |
Why?
| Leukocytes | 1 | 2013 | 290 | 0.030 |
Why?
| beta 2-Microglobulin | 1 | 2011 | 47 | 0.030 |
Why?
| Receptors, Immunologic | 2 | 2003 | 209 | 0.030 |
Why?
| Photochemistry | 1 | 2012 | 136 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2011 | 67 | 0.020 |
Why?
| G-Protein-Coupled Receptor Kinases | 1 | 2010 | 3 | 0.020 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2010 | 8 | 0.020 |
Why?
| GTP-Binding Protein alpha Subunits | 1 | 2010 | 13 | 0.020 |
Why?
| Prospective Studies | 1 | 2022 | 6471 | 0.020 |
Why?
| GTP-Binding Protein beta Subunits | 1 | 2010 | 14 | 0.020 |
Why?
| Calcium Signaling | 2 | 2003 | 219 | 0.020 |
Why?
| Ion Transport | 1 | 2010 | 60 | 0.020 |
Why?
| Perioperative Period | 1 | 2010 | 51 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 332 | 0.020 |
Why?
| Analysis of Variance | 1 | 2013 | 1293 | 0.020 |
Why?
| Infant | 2 | 2016 | 8293 | 0.020 |
Why?
| alpha 1-Antitrypsin | 1 | 2011 | 115 | 0.020 |
Why?
| Interleukin-10 | 1 | 2012 | 306 | 0.020 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 55 | 0.020 |
Why?
| Hemolysis | 1 | 2011 | 174 | 0.020 |
Why?
| Child, Preschool | 2 | 2016 | 9491 | 0.020 |
Why?
| Membrane Microdomains | 1 | 2009 | 35 | 0.020 |
Why?
| Rimantadine | 1 | 2009 | 3 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2011 | 355 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 307 | 0.020 |
Why?
| Mitochondrial Proteins | 1 | 2011 | 226 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2009 | 60 | 0.020 |
Why?
| RNA Interference | 1 | 2011 | 460 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2011 | 446 | 0.020 |
Why?
| Tandem Mass Spectrometry | 1 | 2011 | 421 | 0.020 |
Why?
| Adaptive Immunity | 1 | 2009 | 161 | 0.020 |
Why?
| Platelet-Derived Growth Factor | 1 | 2008 | 83 | 0.020 |
Why?
| Angiogenesis Inducing Agents | 1 | 2008 | 24 | 0.020 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2008 | 91 | 0.020 |
Why?
| Bevacizumab | 1 | 2008 | 124 | 0.020 |
Why?
| Critical Illness | 1 | 2013 | 662 | 0.020 |
Why?
| Aged | 2 | 2019 | 19657 | 0.020 |
Why?
| Bacterial Infections | 1 | 2009 | 227 | 0.020 |
Why?
| Vesicular Transport Proteins | 1 | 2008 | 84 | 0.020 |
Why?
| Tumor Microenvironment | 1 | 2010 | 454 | 0.020 |
Why?
| Carrier Proteins | 1 | 2011 | 726 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2008 | 462 | 0.020 |
Why?
| MAP Kinase Kinase Kinase 5 | 1 | 2006 | 4 | 0.020 |
Why?
| Signal Transduction | 2 | 2010 | 4709 | 0.020 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 219 | 0.020 |
Why?
| Subcellular Fractions | 1 | 2006 | 84 | 0.020 |
Why?
| Cytotoxicity, Immunologic | 1 | 2006 | 204 | 0.020 |
Why?
| Coculture Techniques | 1 | 2006 | 208 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2008 | 462 | 0.020 |
Why?
| Cross-Linking Reagents | 1 | 2006 | 186 | 0.020 |
Why?
| Adolescent | 2 | 2016 | 18480 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2006 | 134 | 0.020 |
Why?
| Intraoperative Care | 1 | 2004 | 39 | 0.020 |
Why?
| Genetic Diseases, X-Linked | 1 | 2004 | 24 | 0.020 |
Why?
| Acyltransferases | 1 | 2004 | 53 | 0.020 |
Why?
| Child | 2 | 2016 | 19129 | 0.020 |
Why?
| Oxidative Stress | 1 | 2011 | 1178 | 0.020 |
Why?
| Tissue Distribution | 1 | 2004 | 334 | 0.010 |
Why?
| Immunity, Innate | 1 | 2009 | 745 | 0.010 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 667 | 0.010 |
Why?
| Lactoferrin | 1 | 2003 | 29 | 0.010 |
Why?
| CD11 Antigens | 1 | 2003 | 32 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 1047 | 0.010 |
Why?
| Alternative Splicing | 1 | 2004 | 193 | 0.010 |
Why?
| Perfusion | 1 | 2003 | 153 | 0.010 |
Why?
| Peroxidase | 1 | 2003 | 170 | 0.010 |
Why?
| Pulmonary Edema | 1 | 2003 | 125 | 0.010 |
Why?
| Macrophage-1 Antigen | 1 | 2002 | 36 | 0.010 |
Why?
| Serine | 1 | 2003 | 138 | 0.010 |
Why?
| Cell Size | 1 | 2002 | 86 | 0.010 |
Why?
| Chemotaxis | 1 | 2003 | 137 | 0.010 |
Why?
| Chelating Agents | 1 | 2002 | 74 | 0.010 |
Why?
| Cell Adhesion | 1 | 2003 | 443 | 0.010 |
Why?
| Colorado | 1 | 2011 | 4196 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2008 | 2851 | 0.010 |
Why?
| Receptors, Cell Surface | 1 | 2003 | 367 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2010 | 4908 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2004 | 2071 | 0.010 |
Why?
| Acute Disease | 1 | 2003 | 940 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2004 | 2871 | 0.010 |
Why?
| Up-Regulation | 1 | 2002 | 872 | 0.010 |
Why?
| Cell Differentiation | 1 | 2004 | 1753 | 0.010 |
Why?
| Pulmonary Artery | 1 | 2003 | 1063 | 0.010 |
Why?
| RNA, Messenger | 1 | 2004 | 2657 | 0.010 |
Why?
| Blood Pressure | 1 | 2003 | 1664 | 0.010 |
Why?
| Membrane Proteins | 1 | 2002 | 1055 | 0.010 |
Why?
| Mutation | 1 | 2004 | 3457 | 0.010 |
Why?
|
|
Kelher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|